ESTEE LAUDER COMPANIES INC EL

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NYSE

The Estée Lauder Companies Inc., founded in 1946 by Estée and Joseph Lauder, is one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. We are a steward of over 20 luxury and prestige brands globally. Since the initial launch of the Estée Lauder brand in the United States, we have significantly expanded our consumer reach to approximately 150 countries and territories. We operate as a wholesaler, with our products sold in brick-and-mortar locations and on various e-commerce platforms, including those operated by department stores, duty-free retailers, specialty-multi retailers, online pure players, upscale perfumeries and pharmacies, and top-tier salons and spas. Additionally, we operate a direct-to-consumer business across freestanding stores, our brands' websites and third-party online platforms.

Last close 103.86 2026-09-04
Market cap $37.63B estimated share count
52-week range 66.22 - 121.64

Valuation FY2026 figures against the last close

P/S2.5x
P/E207.7x
P/FCF28.6x
EV/EBITDA22.0x
Dividend yield1.4%
Diluted EPS0.50

Annual financial statements

Income statement

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue $15.05B$14.33B$15.61B$15.91B$17.74B$16.21B$14.29B$14.86B$13.68B$11.82B
Cost of revenue $3.69B$3.73B$4.42B$4.56B$4.30B$3.83B$3.55B$3.39B$2.84B$2.43B
Gross profit $11.36B$10.60B$11.18B$11.35B$13.43B$12.38B$10.74B$11.48B$10.84B$9.39B
SG&A $9.69B$9.46B$9.62B$9.57B$9.89B$9.37B$8.64B$8.86B$8.55B$7.46B
Total operating expenses $10.58B$11.38B$10.21B$9.84B$10.26B$9.76B$10.14B$9.16B$8.78B$7.69B
Operating income $780.0M-$785.0M$970.0M$1.51B$3.17B$2.62B$606.0M$2.31B$2.06B$1.70B
Interest expense $334.0M$357.0M$378.0M$255.0M$167.0M$173.0M$161.0M$133.0M$128.0M$103.0M
Pre-tax income $517.0M-$1.04B$772.0M$1.40B$3.04B$3.33B$1.05B$2.31B$1.98B$1.62B
Income tax $335.0M$93.0M$363.0M$387.0M$628.0M$456.0M$350.0M$513.0M$863.0M$361.0M
Net income $182.0M-$1.13B$409.0M$1.01B$2.41B$2.88B$696.0M$1.79B$1.11B$1.26B
EPS, basic 0.50-3.151.092.816.647.911.904.913.013.40
EPS, diluted 0.50-3.151.082.796.557.791.864.822.953.35
Shares, diluted (wtd. avg.) $364.8M$360.1M$360.8M$360.9M$364.9M$368.2M$366.9M$370.4M$375.7M$373.0M

Balance sheet

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents $3.50B$2.92B$3.40B$4.03B$3.96B$4.96B$5.02B$2.99B$2.18B$1.14B
Short-term investments $534.0M$605.0M
Receivables $1.52B$1.53B$1.73B$1.45B$1.63B$1.70B$1.19B$1.83B$1.49B$1.40B
Inventory $2.00B$2.07B$2.17B$2.98B$2.92B$2.50B$2.06B$2.01B$1.62B$1.48B
Total current assets $7.61B$7.07B$7.92B$9.14B$9.30B$9.77B$8.89B$7.21B$6.17B$4.96B
Property, plant and equipment $2.81B$3.17B$3.14B$3.18B$2.65B$2.28B$2.06B$2.07B$1.82B$1.67B
Goodwill $2.11B$2.13B$2.14B$2.49B$2.52B$2.62B$1.40B$1.87B$1.93B$1.92B
Other intangibles $3.58B$3.76B$5.18B$5.60B$3.43B$4.09B$2.34B$1.20B$1.28B$1.33B
Total assets $19.76B$19.89B$21.68B$23.41B$20.91B$21.97B$17.78B$13.16B$12.57B$11.57B
Short-term debt $503.0M$3.0M$504.0M$997.0M$268.0M$32.0M$1.22B$516.0M$183.0M$189.0M
Total current liabilities $6.23B$5.43B$5.70B$6.24B$5.82B$5.30B$5.18B$4.61B$3.31B$2.82B
Total liabilities $8.74B
Retained earnings $11.34B$11.67B$13.43B$13.99B$13.91B$12.24B$10.13B$9.98B$9.04B$8.45B
Total equity $3.81B$3.87B$5.31B$5.58B$5.59B$6.09B$3.96B$4.39B$4.71B$4.40B

Cash flow

Fiscal year FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating cash flow $1.77B$1.27B$2.36B$1.73B$3.04B$3.63B$2.28B$2.52B$2.56B$1.79B
Depreciation and amortisation $796.0M$829.0M$825.0M$744.0M$727.0M$651.0M$611.0M$557.0M$531.0M$464.0M
Stock-based compensation $310.0M$304.0M$325.0M$267.0M$331.0M$327.0M$213.0M$243.0M$236.0M$219.0M
Capital expenditure $457.0M$602.0M$919.0M$1.00B$1.04B$637.0M$623.0M$744.0M$629.0M$504.0M
Investing cash flow -$489.0M-$623.0M-$960.0M-$3.22B-$945.0M-$1.86B-$1.70B$473.0M-$358.0M-$2.20B
Financing cash flow -$712.0M-$1.14B-$2.04B$1.59B-$3.04B-$1.89B$1.46B-$2.17B-$1.17B$630.0M
Dividends paid $508.0M$618.0M$947.0M$925.0M$840.0M$753.0M$503.0M$609.0M$546.0M$486.0M
Buybacks $70.0M$35.0M$35.0M$271.0M$2.31B$733.0M$893.0M$1.55B$759.0M$413.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001001250-26-000041.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
ELF e.l.f. Beauty, Inc. $6.47B 249.2x 24.6%
IPAR INTERPARFUMS INC $3.74B 22.3x 2.5%
COTY COTY INC. $2.58B -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.33B 54.5x -1.3%
WALD Waldencast plc $156.3M -0.7%
SLSN SOLESENCE, INC. $60.0M 42.5x 18.6%